Literature DB >> 34286486

2-Deoxy-D-glucose: is this the final cure for COVID-19: or yet another mirage?

S Halder1, A K Mehta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34286486     DOI： 10.26355/eurrev_202107_26234

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN： 1128-3602            Impact factor:   3.507


× No keyword cloud information.
  4 in total

1.  A novel property of hexokinase inhibition by Favipiravir and proposed advantages over Molnupiravir and 2 Deoxy D glucose in treating COVID-19.

Authors:  Prajakta Kulkarni; Sriram Padmanabhan
Journal:  Biotechnol Lett       Date:  2022-05-24       Impact factor: 2.716

Review 2.  T Cell Metabolism in Infection.

Authors:  Jonas Aakre Wik; Bjørn Steen Skålhegg
Journal:  Front Immunol       Date:  2022-03-14       Impact factor: 7.561

3.  SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.

Authors:  Jun-Yi Zhu; Guanglei Wang; Xiaohu Huang; Hangnoh Lee; Jin-Gu Lee; Penghua Yang; Joyce van de Leemput; Weiliang Huang; Maureen A Kane; Peixin Yang; Zhe Han
Journal:  Commun Biol       Date:  2022-09-30

4.  In Silico Evaluation of Binding of 2-Deoxy-D-Glucose with Mpro of nCoV to Combat COVID-19.

Authors:  Anirudh Pratap Singh Raman; Kamlesh Kumari; Pallavi Jain; Vijay Kumar Vishvakarma; Ajay Kumar; Neha Kaushik; Eun Ha Choi; Nagendra Kumar Kaushik; Prashant Singh
Journal:  Pharmaceutics       Date:  2022-01-06       Impact factor: 6.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.